about
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary ...
Read More
4.29
0.08
(1.90%)
199.1K
XNAS Volume
XNAS 11 May, 2026 9:53 AM (EDT)
Board Meeting
The next board meeting for Precigen Inc is on 14 May 2026 for the purpose of Precigen Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Precigen Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..